Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of lifitegrast ophthalmic solution for dry eye disease
CTR20233509Phase 3Completed
- Sponsor
- Lunan Better Pharmaceutical Co., Ltd.
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lifitegrast in dry eye syndrome (DED), sponsored by Lunan Better Pharmaceutical Co., Ltd.. Started Nov 2023; status: completed.
02
Drugs
lifitegrast
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20233509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233509.